Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: The national experience

Liver Transplantation

Volumn 18, Issue 4, 2012, Pages 423-433

  Schwartz, Jason J ^a   Pappas, Lisa ^b   Thiesset, Heather F ^a   Vargas, Gabriela ^a   Sorensen, John B ^a   Kim, Robin D ^a   Hutson, William R ^c   Boucher, Kenneth ^b   Box, Terry ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 84859362304     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23385     Document Type: Article

References (92)

1. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004;10:36-41. (Pubitemid 38885890)
2. Wiesner RH. Patient selection in an era of donor liver shortage: current US policy. Nat Clin Pract Gastroenterol Hepatol 2005;2:24-30. (Pubitemid 40812524)
3. Ioannou GN, Perkins JD, Carithers RL Jr. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008;134:1342-1351. (Pubitemid 351615357)
4. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg 2007;245:51-58. (Pubitemid 46035435)
5. Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-1086. (Pubitemid 32378206)
6. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699. (Pubitemid 26079803)
7. Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997;25:1485-1489. (Pubitemid 27250773)
8. Goodman J, Glasgow SC, Schnitzler M, Lowell JA, Shenoy S, Jendrisak MD, et al. Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease. Arch Surg 2005;140:459-464. (Pubitemid 40617362)
9. Yao FY, Kerlan RK Jr, Hirose R, Davern TJ III, Bass NM, Feng S, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008;48:819-827.
10. Yao FY, Hirose R, LaBerge JM, Davern TJ III, Bass NM, Kerlan RK Jr, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005;11:1505-1514. (Pubitemid 43072626)
11. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007;13:391-399. (Pubitemid 46444468)
12. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007;83:893-899. (Pubitemid 46682729)
13. Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007;246:502-509. (Pubitemid 47312148)
14. Schwartz M, Dvorchik I, Roayaie S, Fiel MI, Finkelstein S, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol 2008;49:581-588.
15. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al.; for Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009;10:35-43.
16. Yao FY, Xiao L, Bass NM, Kerlan RK, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: a 5-year prospective study validating expanded criteria applied to preoperative imaging [abstract]. Hepatology 2006;44(suppl 1):191A.
17. Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, et al. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 2009;15:859-868.
18. Facciuto ME, Rochon C, Pandey M, Rodriguez-Davalos M, Samaniego S, Wolf DC, et al. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) 2009;11:398-404.
19. Charpentier KP, Cheah YL, Machan JT, Miner T, Morrissey P, Monaco A. Intention to treat survival following liver transplantation for hepatocellular carcinoma within a donor service area. HPB (Oxford) 2008;10:412-415.
20. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003;238:508-518.
21. Mailey B, Buchberg B, Prendergast C, Artinyan A, Khalili J, Sanchez-Luege N, et al. A disease-based comparison of liver transplantation outcomes. Am Surg 2009;75:901-908.
22. Herrero JI, Lucena JF, Quiroga J, Sangro B, Pardo F, Rotellar F, et al. Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 2003;3:1407-1412. (Pubitemid 37288086)
23. Ghobrial RM, Gornbein J, Steadman R, Danino N, Markmann JF, Holt C, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002;236:315-322.
24. Aloia TA, Knight R, Gaber AO, Ghobrial RM, Goss JA. Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple Model for End-Stage Liver Disease-independent prognostic factors. Liver Transpl 2010;16:950-959.
25. Arbor Research Collaborative for Health. Fast facts. http://www.srtr.org/ annual-reports/2010/chapter-index.htm. Accessed March 14, 2012.
26. Montalti R, Rompianesi G, Di Benedetto F, Ballarin R, Gerring RC, Busani S, et al. Liver transplantation in patients aged 65 and over: a case-control study. Clin Transplant 2010;24:E188-E193.
27. Organ Procurement and Transplantation Network. Data. http://optn. transplant.hrsa.gov/data. Accessed December 2011.
28. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:331-338. (Pubitemid 36443043)
29. Aduen JF, Sujay B, Dickson RC, Heckman MG, Hewitt WR, Stapelfeldt WH, et al. Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc 2009;84:973-978.
30. Cross TJ, Antoniades CG, Muiesan P, Al-Chalabi T, Aluvihare V, Agarwal K, et al. Liver transplantation in patients over 60 and 65 years: an evaluation of longterm outcomes and survival. Liver Transpl 2007;13:1382-1388. (Pubitemid 47629570)
31. Pirsch JD, Kalayoglu M, D'Alessandro AM, Voss BJ, Armbrust MJ, Reed A, et al. Orthotopic liver transplantation in patients 60 years of age and older. Transplantation 1991;51:431-433.
32. Shaw BJ Jr. Liver transplantation in patients over 60 years of age. In: Liver Update: Function and Disease. Cedar Grove, NJ: American Liver Foundation; 1992:3-4.
33. Emre S, Mor E, Schwartz ME, Katz E, Acarli K, Fukuzawa K, Miller CM. Liver transplantation in patients beyond age 60. Transplant Proc 1993;25(pt 2):1075-1076. (Pubitemid 23078902)
34. Box T, Keeffe E, Esquivel C. Liver transplantation in elderly patients. Pract Gastroenterol 1993;17:22-27.
35. Castaldo P, Langnas AN, Stratta RJ, Wood RP, Shaw BW Jr. Liver transplantation in patients over 60 years of age [abstract]. Gastroenterology 1991;100:A727.
36. Bromley PN, Hilmi I, Tan KC, Williams R, Potter D. Orthotopic liver transplantation in patients over 60 years old. Transplantation 1994;58:800-803. (Pubitemid 24329183)
37. de la Peña A, Herrero JI, Sangro B, Pardo F, Hernández JL, Alvarez-Cienfuegos J, et al. Liver transplantation in cirrhotic patients over 60 years of age [in Spanish and English]. Rev Esp Enferm Dig 1998;90:3-14.
38. Rudich S, Busuttil R. Similar outcomes, morbidity, and mortality for orthotopic liver transplantation between the very elderly and the young. Transplant Proc 1999;31:523-525. (Pubitemid 29127556)
39. Yoshizumi T, Shirabe K, Soejima Y, Taketomi A, Yamashita N, Ikegami T, et al. Living donor liver transplantation in patients older than 60 years. Transplantation 2010;90:433-437.
40. Lipshutz GS, Hiatt J, Ghobrial RM, Farmer DG, Martinez MM, Yersiz H, et al. Outcome of liver transplantation in septuagenarians: a single-center experience. Arch Surg 2007;142:775-781. (Pubitemid 47295742)
41. Keswani RN, Ahmed A, Keeffe EB. Older age and liver transplantation: a review. Liver Transpl 2004;10:957-967. (Pubitemid 39232748)
42. Zetterman RK, Belle SH, Hoofnagle JH, Lawlor S, Wei Y, Everhart J, et al. Age and liver transplantation: a report of the Liver Transplantation Database. Transplantation 1998;66:500-506. (Pubitemid 28415378)
43. Levy MF, Somasundar PS, Jennings LW, Jung GJ, Molmenti EP, Fasola CG, et al. The elderly liver transplant recipient: a call for caution. Ann Surg 2001;233:107-113. (Pubitemid 32042780)
44. Collins BH, Pirsch JD, Becker YT, Hanaway MJ, Van der Werf WJ, D'Alessandro AM, et al. Long-term results of liver transplantation in older patients 60 years of age and older. Transplantation 2000;70:780-783.
45. Merli M, Nicolini G, Gentili F, Novelli G, Iappelli M, Casciaro G, et al. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc 2005;37:2535-2540. (Pubitemid 41354662)
46. Bilbao I, Dopazo C, Lazaro JL, Castells L, Escartin A, Lopez I, et al. Our experience in liver transplantation in patients over 65 yr of age. Clin Transplant 2008;22:82-88. (Pubitemid 351150007)
47. Sotiropoulos GC, Molmenti EP, Lang H. Liver transplantation for hepatocellular carcinoma in the MELD era: leading roles of MELD score, AFP level, and recipient age as predictors of survival. Dig Dis Sci 2009;54:917.
48. Sotiropoulos GC, Lang H, Sgourakis G, Nadalin S, Molmenti EP, Radtke A, et al. Liberal policy in living donor liver transplantation for hepatocellular carcinoma: lessons learned. Dig Dis Sci 2009;54:377-384.
49. Popescu I. Living donor liver transplantation for hepatocellular carcinoma: defining criteria to extend indications. Dig Dis Sci 2009;54:199-200.
50. Gordon T, Kannel WB, eds. The Framingham Study: Introduction and General Background in The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 1. Bethesda: National Heart Institute, 1968.
51. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995;59:859-864.
52. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996;2:426-430. (Pubitemid 26386861)
53. Leidig-Bruckner G, Hosch S, Dodidou P, Ritschel D, Conradt C, Klose C, et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 2001;357:342-347. (Pubitemid 32128540)
54. Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 2001;69:321-326. (Pubitemid 34056794)
55. Hay JE. Osteoporosis. Clin Liver Dis 1998;2:407-419.
56. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001;34:84-91. (Pubitemid 32102556)
57. Xiol X, Guardiola J, Menendez S, Lama C, Figueras J, Marcoval J, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001;7:971-975. (Pubitemid 33085786)
58. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000;69:781-789. (Pubitemid 30174097)
59. Rabkin JM, de La Melena V, Orloff SL, Corless CL, Rosen HR, Olyaei AJ. Late mortality after orthotopic liver transplantation. Am J Surg 2001;181:475-479. (Pubitemid 32614121)
60. Fong Y, Blumgart LH, Fortner JG, Brennan MF. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 1995;222:426-434.
61. Cosenza CA, Hoffman AL, Podesta LG, Sher L, Lopez RR, Lugo D, Makowka L. Hepatic resection for malignancy in the elderly. Am Surg 1995;61:889-895. (Pubitemid 26085145)
62. Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J Gastrointest Surg 2009;13:1627-1635.
63. Lui WY, Chau GY, Wu CW, King KL. Surgical resection of hepatocellular carcinoma in elderly cirrhotic patients. Hepatogastroenterology 1999;46:640-645.
64. Poon RT, Fan ST, Lo CM, Liu CL, Ngan H, Ng IO, Wong J. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999;94:2460-2466. (Pubitemid 29420674)
65. Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005;100:2708-2716.
66. Todo S, Furukawa H; for Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004;240:451-459.
67. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998;228:479-490. (Pubitemid 30194392)
68. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000;88:538-543. (Pubitemid 30056926)
69. Vauthey JN, Ajani JA. Liver transplantation and hepatocellular carcinoma biology: beginning of the end of the era of educated guesses. J Clin Oncol 2003;21:4265-4267. (Pubitemid 46621799)
70. Onaca N, Klintmalm GB. Liver transplantation for hepatocellular carcinoma: the Baylor experience. J Hepatobiliary Pancreat Sci 2010;17:559-566.
71. Koperna T, Kisser M, Schulz F. Hepatic resection in the elderly. World J Surg 1998;22:406-412. (Pubitemid 28113530)
72. Nagasue N, Chang YC, Takemoto Y, Taniura H, Kohno H, Nakamura T. Liver resection in the aged (seventy years or older) with hepatocellular carcinoma. Surgery 1993;113:148-154. (Pubitemid 23060522)
73. Ezaki T, Yukaya H, Ogawa Y. Evaluation of hepatic resection for hepatocellular carcinoma in the elderly. Br J Surg 1987;74:471-473. (Pubitemid 17085662)
74. Mentha G, Huber O, Robert J, Klopfenstein C, Egeli R, Rohner A. Elective hepatic resection in the elderly. Br J Surg 1992;79:557-559.
75. Takenaka K, Shimada M, Higashi H, Adachi E, Nishizaki T, Yanaga K, et al. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg 1994;129:846-850. (Pubitemid 24249141)
76. Pérez-Saborido B, de los Galanes SJ, Meneu-Díaz JC, Romero CJ, Elola-Olaso AM, Suárez YF, et al. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors. Transplant Proc 2007;39:2304-2307. (Pubitemid 47418167)
77. Chen WT, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol 2004;30:414-420.
78. Fortner JG, Lincer RM. Hepatic resection in the elderly. Ann Surg 1990;211:141-145. (Pubitemid 20063200)
79. O'Grady JG. Treatment options for other hepatic malignancies. Liver Transpl 2000;6(suppl 2):S23-S29.
80. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181-200. (Pubitemid 40781071)
81. Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, Zanus G, et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004;239:150-159. (Pubitemid 38176347)
82. Santoyo J, Suarez MA, Fernández-Aguilar JL, Jiménez M, Perez Daga JA, Sánchez-Perez B, et al. Liver transplant results for hepatocellular carcinoma applying strict preoperative selection criteria. Transplant Proc 2005;37:1488-1490. (Pubitemid 40712094)
83. Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003;21:4329-4335. (Pubitemid 46621808)
84. Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, et al. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl 2004;10:1343-1354. (Pubitemid 39530049)
85. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 2009;49:832-838.
86. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995;169:28-34.
87. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002;20:1527-1536. (Pubitemid 34260532)
88. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-659. (Pubitemid 32378649)
89. Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002;6:224-232. (Pubitemid 40433575)
90. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403. (Pubitemid 32496976)
91. Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 2010;116:1367-1377.
92. Reese PP, Caplan AL, Bloom RD, Abt PL, Karlawish JH. How should we use age to ration health care? Lessons from the case of kidney transplantation. J Am Geriatr Soc 2010;58:1980-1986.